Real-world efficacy and toxicity of tebentafusp in metastatic uveal melanoma patients treated on the United Kingdom expanded access programme.

Joseph M, Tharakan J, Proudfoot-Jones J, Sacco JJ, Furness A, McMahon D, Khoja L, Pallan L, Serra P, Ranatunge D, Oladipo B, Clements G, Mariappan L, Hennah L, Talbot T, Nobes J, Carter T, Shaw H, Nathan P

Open source

DOI: 10.1093/oncolo/oyag341
Published: 2026 Sep 9
Container: The oncologist
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag341,
  title = {Real-world efficacy and toxicity of tebentafusp in metastatic uveal melanoma patients treated on the United Kingdom expanded access programme.},
  author = {Joseph M and Tharakan J and Proudfoot-Jones J and Sacco JJ and Furness A and McMahon D and Khoja L and Pallan L and Serra P and Ranatunge D and Oladipo B and Clements G and Mariappan L and Hennah L and Talbot T and Nobes J and Carter T and Shaw H and Nathan P},
  year = {2026},
  journal = {The oncologist},
  doi = {10.1093/oncolo/oyag341},
  url = {https://doi.org/10.1093/oncolo/oyag341}
}

RIS

TY  - JOUR
TI  - Real-world efficacy and toxicity of tebentafusp in metastatic uveal melanoma patients treated on the United Kingdom expanded access programme.
AU  - Joseph M
AU  - Tharakan J
AU  - Proudfoot-Jones J
AU  - Sacco JJ
AU  - Furness A
AU  - McMahon D
AU  - Khoja L
AU  - Pallan L
AU  - Serra P
AU  - Ranatunge D
AU  - Oladipo B
AU  - Clements G
AU  - Mariappan L
AU  - Hennah L
AU  - Talbot T
AU  - Nobes J
AU  - Carter T
AU  - Shaw H
AU  - Nathan P
PY  - 2026
JO  - The oncologist
DO  - 10.1093/oncolo/oyag341
UR  - https://doi.org/10.1093/oncolo/oyag341
ER  -

APA

M, J., J, T., J, P., JJ, S., A, F., D, M., L, K., L, P., P, S., D, R., B, O., G, C., L, M., L, H., T, T., J, N., T, C., H, S., & P, N. (2026). Real-world efficacy and toxicity of tebentafusp in metastatic uveal melanoma patients treated on the United Kingdom expanded access programme.. The oncologist. https://doi.org/10.1093/oncolo/oyag341

Source records

pubmed · retrieved 2026-09-25T17:11:56.236Z